Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.
Negocios · 23/9/20241 min de lectura
Progynon Associates, et al.; Withdrawal of Approval of Four New Drug Applications
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is withdrawing approval of four new drug applications (NDAs) from multiple holders of those NDAs. The basis for the withdrawal is that these NDA holders have repeatedly failed to file required annual reports for the identified NDAs.
Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →